Week 6🌟

Psychology 745: Psychopathology - Anxiety Disorders

Instructor Information

  • Martin McElhiney, Ph.D.

Overview of Anxiety Disorders

  • Anxiety Disorders Referenced in Castonguay, Chapter 4:
    • Panic Disorder
    • Characterized by recurrent panic attacks with a rapid onset of physical symptoms.
    • Symptoms may include:
      • Racing heart
      • Shortness of breath
    • Accompanied by a fear of future attacks.
    • Agoraphobia
    • Involves avoidance of situations where panic or anxiety might occur, especially when escape may be difficult.
    • Social Anxiety (Social Phobia)
    • Intense anxiety or avoidance of social situations due to fear of negative evaluation.
    • Specific Phobias
    • Excessive fear of specific objects or situations (e.g., spiders, heights, enclosed spaces).
    • Overlap of Symptoms
    • Many symptoms across various anxiety disorders are overlapping, suggesting a need for a dimensional model that could better explain the range of anxiety problems rather than a rigid DSM category system.

Typical Symptoms and Clinical Features

  • Excessive Distress:
    • Often disproportionate to the objective danger present in the environment.
  • Avoidance Behaviors:
    • Individuals may attempt to escape or avoid certain feared situations, resulting in functional impairments (socially or occupationally).
  • Information Processing:
    • Anxious individuals may process information in a manner that reinforces negative beliefs about the world and its dangers.
  • Physiological Reactions:
    • Commonality of a “fight or flight” reaction across anxiety disorders characterized by autonomic arousal.
  • Sympathetic Nervous System Activation:
    • Pathophysiology Includes:
    • Increased heart rate
    • Rapid breathing
    • Inhibition of digestive processes
    • Vasoconstriction in certain body areas and vasodilation in muscles.
    • Pupil dilation
    • Release of endorphins
    • Acceleration of reflexes.

Autonomic Nervous System

  • Sympathetic Nervous System:
    • Role:
    • Responsible for the “fight or flight” response, preparing the body for potential danger.
    • Characteristics:
    • Short neuron pathways for rapid response.
    • Increases in heartbeat; muscle tension.
    • Pupil dilation for enhanced visual clarity.
    • Saliva secretion is inhibited.
  • Parasympathetic Nervous System:
    • Role:
    • Involved in homeostasis and the “rest and digest” response.
    • Characteristics:
    • Long neuron pathways, resulting in slower response times.
    • Reduces heartbeat; muscle relaxation.
    • Pupil constriction; increased saliva secretion;
    • Promotes digestive processes.

Anxiety Disorders as per DSM-5-TR

  • Categories:
    • Separation Anxiety Disorder
    • Selective Mutism
    • Specific Phobia
    • Social Anxiety Disorder
    • Panic Disorder
    • Agoraphobia
    • Generalized Anxiety Disorder
    • Substance/Medication-Induced Anxiety Disorder
    • Anxiety Disorder Due to Another Medical Condition
    • Other Specified Anxiety Disorder.

Illness Course: Panic Disorder and Agoraphobia

  • Panic Attack Patterns:
    • Attacks may vary in frequency (waxing and waning).
    • Life stressors can predict both the onset and frequency of episodes.
    • Generally, these conditions are chronic and disabling; relapse after remission is common.
  • Longitudinal Findings:
    • In a 5-year follow-up study:
    • 38% in remission
    • 44% with mild symptoms and phobic avoidance
    • 19% relapsed or unchanged.
  • Summary: Indicates that residual symptoms are common, and relapse is expected.

Illness Course: Social Anxiety Disorder

  • Chronic Nature:
    • Tends to persist, with low recovery rates and high rates of recurrence, especially when untreated.
    • Estimates suggest duration anywhere between 19 and 30 years.
    • Naturalistic recovery rates are low, ranging from 20-40%.
    • Prospective studies suggest only a 37% chance of recovery over 12 years with a 39% chance of recurrence after recovery.
  • Conclusion: Social anxiety disorder is often long-lasting and may remain untreated without intervention.

Illness Course: Specific Phobia

  • Stability:
    • Not much data available; however, some phobias in adults appear stable when untreated.
    • Many children tend to outgrow phobias over time.
    • Seeking treatment is rare, but those who do often benefit from therapies like exposure therapy.

Epidemiology

Past Year Prevalence (U.S. Adults 2001-2003)
  • Data sourced from the National Comorbidity Survey Replication (NCS-R):
    • Overview of anxiety disorders in adults by sex and age.
    • Approx rates with noted variations across demographics.
    • Graph Analysis: Displayed percentage data on various demographics (female, male, and age categories).

Lifetime Prevalence Among Adolescents (2001-2004)
  • Data sourced from the National Comorbidity Survey Adolescent Supplement (NCS-A):
    • Insights into prevalence in adolescent groups.
    • Overall rates and severe impairments broken down by age groups.

Past Year Severity of Anxiety Disorders (U.S. Adults 2001-2003)
  • Severity categories compiled via NCS-R, indicating serious, moderate, and mild instances.
  • Statistics:
    • Serious: 22.8%
    • Moderate: 33.7%
    • Mild: 43.5%

Epidemiology: Panic Disorder and Agoraphobia
  • Lifetime Prevalence:
    • Ranges from 3.8% to 4.7% for panic disorder (with or without agoraphobia).
    • 1-year prevalence estimates between 1.8% and 2.4%.
    • Agoraphobia without panic occurs in approximately 2.5% lifetime prevalence.
    • Median age of onset: 24.
    • Notable Puberty as predictor for panic attacks, new onset in older adults often linked to life stressors.
    • Gender disparity consistently reports a ratio of approximately 2:1 (women to men).
    • Comparison across cultures shows consistency in prevalence rates and onset age.

Epidemiology: Social Anxiety Disorder
  • Lifetime Prevalence:
    • Estimated between 3 and 13% in Western cultures, with the NCS-R indicating 12.1%.
    • Median age of onset is typically 13 years, with rates decreasing into later life.
    • Notable prevalence differences observed across sexes and treatments.
    • Cultural impacts reveal lower prevalence in Southeast Asian countries compared to Western standards.

Epidemiology: Specific Phobia
  • Variation in Prevalence:
    • Lifetime prevalence ranges from 6 to 12%.
    • Some individuals report sub-clinical fears; common fears include animals and heights.
    • Mean onset age is noted at 8 years old, with variations in phobia types (e.g., blood-injury phobia often noted in childhood).
    • Highest prevalence occurs in childhood/adolescence, with stability observed in adulthood until mid-50s.
    • Similar to other anxiety disorders, more prevalent among women; treatment-seeking studies indicate higher success rates for women.

Comorbidity Considerations

Panic Disorder and Agoraphobia
  • Comorbid Disorders:
    • Approximately 83% of individuals with panic disorder have at least one additional psychiatric disorder.
    • Notably, 20% meet criteria for agoraphobia, particularly higher in clinical settings.
    • High occurrence with anxiety disorders (e.g., generalized anxiety disorder and specific phobias).
    • Common mood disorder comorbidities include major depression in about 35-40% of individuals with panic disorder.
    • Reports of substance misuse crossing 20%; often, panic symptoms precede substance use.
    • Medical comorbidity is also prevalent, given overlapping symptomatology with stenosis, heart disease, and respiratory disorders.

Social Anxiety Disorder Comorbidity
  • Prevalent Comorbidities:
    • 25-100% may also fulfill avoidant personality disorder criteria.
    • Lifetime coexisting disorders range from 63% to 82% in individuals diagnosed with social anxiety disorder.
    • Alcohol use disorders noted: 7.2% abuse, 9.3% dependence.
    • Age of onset for social anxiety often predates comorbid disorders; disparities range depending on the nature of the disorder.

Specific Phobia Comorbidity
  • Research indicates that specific phobias often co-occur with others; sometimes, individuals present with multiple phobias.
    • Prior estimates suggest only 18% of individuals had multiple specific phobias, though newer studies dispute that.

Etiology

  • Chapter authors outline three vulnerability and causal factors' interactions leading to anxiety outcomes:
    • Biological Vulnerability: Increases susceptibility to anxiety.
    • General Psychological Vulnerability: Resulting from an environment viewed as uncontrollable/unpredictable, can lead to “false alarms”.
    • Specific Psychological Vulnerabilities: Based on personal learning experiences regarding threatening environmental aspects.

Measures for Assessing Anxiety Disorders

  • Common Assessment Tools:
    • Beck Anxiety Inventory (BAI)
    • Spielberger State-Trait Anxiety Inventory (STAI)
    • Hamilton Anxiety Rating Scale (HAM-A)
    • Severity measures specific to social anxiety disorder and specific phobia.

Assessment Details

Beck Anxiety Inventory (BAI)
  • Self-report measure consisting of 21 items assessing anxiety.
    • Reliability: Cronbach's alpha = 0.92; Test-retest reliability (1 week) = 0.75
    • Validity: Moderate correlation with Hamilton Anxiety Rating Scale (0.51).
    • Scoring:
    • Score Breakdown:
      • 0-21: Low anxiety
      • 22-35: Moderate anxiety
      • 36+: Potentially concerning levels of anxiety.

Spielberger State-Trait Anxiety Inventory (STAI)
  • Assessment tool consisting of self-descriptive statements rated based on current feelings.
    • Evaluated on a 4-point Likert scale.

Hamilton Anxiety Rating Scale (HAM-A)
  • Includes questions about mood, tension, fears, insomnia, and somatic symptoms.
    • Ratings given based on severity across multiple domains.

Severity Measures for Social Anxiety Disorder
  • 10-item questionnaire to assess severity of symptoms in social settings; scoring from 0 to 40 based on frequency.

Severity Measure for Specific Phobia
  • Similar to the social anxiety measure but focused on specific phobic stimuli, utilizing a 5-point severity scale.